Business Context and Reporting Period
This Form 8-K was filed by Galectin Therapeutics Inc. on September 25, 2019. The report addresses corporate governance matters regarding the scheduling of the company's 2019 Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding shareholder meeting logistics and does not contain financial statements or performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the Board of Directors' establishment of dates for the 2019 Annual Meeting. Notably, the company did not hold an annual meeting in the previous year.
Guidance, Outlook, and Management Commentary
- Meeting Date: The 2019 Annual Meeting is scheduled for Wednesday, December 4, 2019.
- Record Date: The record date for determining stockholders entitled to vote is Thursday, October 10, 2019.
- Proposal Deadlines: Stockholders wishing to submit proposals under Rule 14a-8 or nominate directors under the By-Laws must submit written notice by the close of business on October 7, 2019.
- Submission Address: Proposals must be sent to the Corporate Secretary at 4960 Peachtree Industrial Blvd., Suite 240, Norcross, GA 30071.
Investor Verification Checklist
- Verify the record date of October 10, 2019, to confirm eligibility to vote at the December 4, 2019 meeting.
- Confirm the October 7, 2019 deadline for submitting shareholder proposals or director nominations.
- Review the company's Amended and Restated By-Laws for specific requirements regarding director nominations and business proposals.
- Note that the company missed holding an annual meeting in the prior year.